Study to Assess the Acceptability/Swallowability of DRV-Containing FDC Tablets in HIV-1 Infected Adolescents, Using Matching Placebo Tablets

NCT02993237 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV-1

Interventions

DRUG: DRV/COBI FDC placebo tablet
DRUG: D/C/F/TAF FDC placebo tablets

Sponsor

Janssen Research & Development, LLC